A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney TransplantRecipients at High-Risk of Cytomegalovirus Infection, LionHeart21

Project: Research project

Project Details

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of NPC-21 for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection, LionHeart21
StatusActive
Effective start/end date6/12/206/30/25

Funding

  • NOBELPHARMA CO., LTD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.